Incannex Healthcare Inc ADR (IXHL) Stock Price, Quote & News

Company Profile

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that is in Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety diso...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 61 4 0984 0786

Website: www.incannex.com

Address:

8 Century Circuit, Suite 105 Norwest, Sydney, Australia

Mamalama May. 13 at 1:19 PM

$IXHL reporting ildijanaMM for spam so sick of his shit.

0 · Reply

ShorterkingaTM May. 13 at 1:14 PM

$IXHL people still watching this stock lamp? Ernesto is still alive? LMAO GERMAN LOSER. You lost all your money lmao

0 · Reply

Michaelthoaicaonguyen May. 13 at 1:12 PM

$IXHL another fucknutt complaining about me cursing. Yeah I curse I’m only human. That doesn’t make me non religious person. If God condemn all who curse than I guess 90% of the people at my church will be condemn. Get the fuck outta here.

1 · Reply

Paxhawig May. 13 at 1:10 PM

$IXHL bullshit

0 · Reply

NAKRiches May. 13 at 1:05 PM

$IXHL Hold strong and add a few on dips for best longer term results..

0 · Reply

ratofalcantarilla86 May. 13 at 12:46 PM

$IXHL bro … u are a loser 🤣🤣🤣 wherever u are … people lose money 🤣🤣🤣🤣 change job 🤣🤣🤣

1 · Reply

bound4glory May. 13 at 12:17 PM

$IXHL Trading around $0.13 pre-split. Sad. But they do have some nice awards hanging in corporate. Probably with gold frames. 😀

1 · Reply

J4y000 May. 13 at 12:03 PM

$IXHL what is this price action? Earnings out today maybe or someone knows something… 👀

1 · Reply

Michaelthoaicaonguyen May. 13 at 11:51 AM

$IXHL oh it’s ok for those give buyout narrative everyday but it’s not ok for me to talk about this great stock with shitty jerkoff Joel being in charge. So fucking what if I post 40,000 time a day. Don’t fucking read it. Yeah I do have a fucking life. I go to the gym 3 hours a day/5 days a week. I work 6 days a week 10 hours a day. On my days off I help my church and go to the senior center to help out. What the fuck do you do when you’re not on this board. Don’t like me block me all you fucknuts.

2 · Reply

Nawaf643 May. 13 at 11:41 AM

$IXHL ⬆️⚡️

0 · Reply

Incannex Healthcare Wins MedTech Breakthrough Award for IHL-42X, Underscoring Leadership in Next-Generation Drug Development

May 7, 2026, 10:00 AM EDT - 5 days ago

Incannex Healthcare Recognized for Innovative Drug Development Solutions by MedTech Breakthrough

Apr 22, 2026, 8:00 AM EDT - 21 days ago

Incannex Healthcare PSX-001 Program Aligns with White House Executive Order Accelerating Access to Psychedelic Treatments for Serious Mental Illness

2026-04-16T12:37:21.000Z - 27 days ago

Two new option listings on April 16th

CSHR

2026-04-16T12:31:09.000Z - 27 days ago

Two new option listings on April 16th

CSHR

2026-03-27T12:12:54.000Z - 6 weeks ago

Incannex reactivates share repurchase program

Mar 27, 2026, 8:00 AM EDT - 6 weeks ago

Incannex Reactivates Share Repurchase Program, Underscoring Confidence in Valuation and Strategic Position

2026-03-25T12:11:47.000Z - 7 weeks ago

Incannex enters partnership agreement with American Academy of Sleep Medicine

Mar 25, 2026, 8:00 AM EDT - 7 weeks ago

Incannex Healthcare Announces Partnership with the AASM Foundation in Support of Sleep Apnea Research

2026-03-18T12:27:15.000Z - 2 months ago

Incannex reports balance sheet with $75M in cash, no debt

Mar 18, 2026, 8:00 AM EDT - 2 months ago

Incannex Highlights Strong Balance Sheet with Approximately $75 Million in Cash and No Debt as Company Advances IHL-42X Development

2026-03-17T12:16:04.000Z - 2 months ago

Incannex regains compliance with Nasdaq minimum bid price rule

Mar 17, 2026, 8:00 AM EDT - 2 months ago

Incannex Regains Compliance with Nasdaq Minimum Bid Price Requirement

2026-03-12T12:27:43.000Z - 2 months ago

Incannex prices 2M shares at $5.00 in registered direct offering

2026-03-12T12:21:15.000Z - 2 months ago

Incannex announces enhanced development strategy for IHL-42X

Mar 12, 2026, 8:05 AM EDT - 2 months ago

Incannex Healthcare Inc. Announces Pricing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

2026-02-27T00:50:18.000Z - 2 months ago

Incannex Healthcare Inc trading halted, news pending

2026-02-25T14:29:04.000Z - 2 months ago

Incannex board approves 1-for-30 reverse stock split

Feb 25, 2026, 9:20 AM EST - 2 months ago

Incannex Announces Reverse Stock Split

Feb 18, 2026, 6:35 PM EST - 2 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2026

2026-01-29T13:16:52.000Z - 3 months ago

Incannex announces additional appointments to Clinical Advisory Board

Jan 29, 2026, 8:00 AM EST - 3 months ago

Incannex Healthcare Announces Additional Appointments to Clinical Advisory Board

2026-01-22T13:21:38.000Z - 3 months ago

Incannex announces formation of clinical advisory board for PSX-001 program

Jan 22, 2026, 8:00 AM EST - 3 months ago

Incannex Healthcare Announces Formation of Clinical Advisory Board for PSX-001 Program

Jan 15, 2026, 8:00 AM EST - 4 months ago

Incannex Healthcare Wins Research and Development Award for Obstructive Sleep Apnea Program in the 2025 Clinical Trials Arena Excellence Awards

2026-01-14T13:05:23.000Z - 4 months ago

Incannex delivers 2025 review, outlines 2026 outlook

Jan 14, 2026, 8:00 AM EST - 4 months ago

Incannex Healthcare Delivers Transformational 2025 Progress and Outlines Well-Funded Outlook for 2026

2025-12-03T13:10:21.000Z - 5 months ago

Incannex granted Fast Track designation for IHL-42X in OSA

Dec 3, 2025, 8:00 AM EST - 5 months ago

Incannex Granted FDA Fast Track Designation for IHL-42X in Obstructive Sleep Apnea (OSA)

Nov 20, 2025, 9:34 AM EST - 6 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2026

2025-10-30T12:28:51.000Z - 6 months ago

Incannex provides shareholder update including 2025 priorities

Oct 30, 2025, 8:00 AM EDT - 6 months ago

Incannex Provides Shareholder Update Highlighting Clinical Progress, Capital Discipline, and EOY 2025 Strategic Focus

2025-10-22T12:05:51.000Z - 7 months ago

Incannex granted 180-day extension by Nasdaq to regain compliance

Oct 22, 2025, 8:00 AM EDT - 7 months ago

Incannex Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

Aug 26, 2025, 8:00 AM EDT - 9 months ago

Incannex Reports Positive Results from Phase 2 Clinical Trial of PSX-001 (Psi-GAD) for Generalised Anxiety Disorder

Aug 22, 2025, 8:00 AM EDT - 9 months ago

Incannex Healthcare Authorizes $20 Million Share Repurchase Program

Aug 19, 2025, 4:29 PM EDT - 9 months ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Update

Aug 8, 2025, 8:00 AM EDT - 9 months ago

Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea

Jul 31, 2025, 8:00 AM EDT - 10 months ago

Incannex Confirms Strong Cash Position; No Plans or Requirement to Fully Utilise ATM in Near Term

Jul 30, 2025, 8:00 AM EDT - 10 months ago

Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X

Jul 25, 2025, 7:30 AM EDT - 10 months ago

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Charlene E. Gamaldo

Jun 24, 2025, 7:30 AM EDT - 11 months ago

Incannex Healthcare Expands Clinical Advisory Board to Support Obstructive Sleep Apnea Program with Appointment of Dr. Douglas B. Kirsch

Jun 18, 2025, 7:30 AM EDT - 11 months ago

Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X

Jun 17, 2025, 7:30 AM EDT - 11 months ago

Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy

Jun 12, 2025, 7:30 AM EDT - 11 months ago

Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution

Jun 3, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Inc. Expands IHL-42X Clinical Advisory Board with Appointments of Four Industry and Academic Leaders to Advance Obstructive Sleep Apnea (OSA) Program

May 29, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance

May 28, 2025, 4:21 PM EDT - 1 year ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025

May 28, 2025, 7:00 AM EDT - 1 year ago

Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results

May 20, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Inc. Executes Strategic Cancellation of 50.4% of Series A Warrants, Significantly Reducing Potential Dilution

May 16, 2025, 9:00 AM EDT - 1 year ago

Incannex Announces Potential Reduction of Up to 50.4% of its Series A Warrants

May 15, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates

May 14, 2025, 8:00 AM EDT - 1 year ago

Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Apr 3, 2025, 7:30 AM EDT - 1 year ago

Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

Mar 7, 2025, 2:10 PM EST - 1 year ago

Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules

Feb 18, 2025, 5:51 PM EST - 1 year ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025

Feb 14, 2025, 7:30 AM EST - 1 year ago

Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates

Feb 4, 2025, 9:15 AM EST - 1 year ago

Incannex Healthcare Appoints Alison Wimms, Ph.D. to Newly Formed IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board

Jan 23, 2025, 7:30 AM EST - 1 year ago

Incannex Healthcare Announces Positive Topline Results from Pharmacokinetics (PK) Study of IHL-42X, an Oral Combination Medicine for the Treatment of Obstructive Sleep Apnea

Dec 2, 2024, 4:48 PM EST - 1 year ago

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2025

Nov 14, 2024, 4:05 PM EST - 1 year ago

Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates

Oct 24, 2024, 7:30 AM EDT - 1 year ago

Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer

Oct 2, 2024, 4:50 PM EDT - 1 year ago

Stonegate Initiates Coverage on Incannex Healthcare Inc. (IXHL)

Sep 30, 2024, 4:01 PM EDT - 1 year ago

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates

Sep 9, 2024, 8:00 AM EDT - 1 year ago

Sleep Apnea Pill: Quantum Research Survey Shows Sleep Apnea Patients Seeking CPAP Alternatives

Aug 5, 2024, 7:30 AM EDT - 1 year ago

FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed

Mamalama May. 13 at 1:19 PM

$IXHL reporting ildijanaMM for spam so sick of his shit.

0 · Reply

ShorterkingaTM May. 13 at 1:14 PM

$IXHL people still watching this stock lamp? Ernesto is still alive? LMAO GERMAN LOSER. You lost all your money lmao

0 · Reply

Michaelthoaicaonguyen May. 13 at 1:12 PM

1 · Reply

Paxhawig May. 13 at 1:10 PM

$IXHL bullshit

0 · Reply

NAKRiches May. 13 at 1:05 PM

$IXHL Hold strong and add a few on dips for best longer term results..

0 · Reply

ratofalcantarilla86 May. 13 at 12:46 PM

$IXHL bro … u are a loser 🤣🤣🤣 wherever u are … people lose money 🤣🤣🤣🤣 change job 🤣🤣🤣

1 · Reply

bound4glory May. 13 at 12:17 PM

$IXHL Trading around $0.13 pre-split. Sad. But they do have some nice awards hanging in corporate. Probably with gold frames. 😀

1 · Reply

J4y000 May. 13 at 12:03 PM

$IXHL what is this price action? Earnings out today maybe or someone knows something… 👀

1 · Reply

Michaelthoaicaonguyen May. 13 at 11:51 AM

2 · Reply

Nawaf643 May. 13 at 11:41 AM

$IXHL ⬆️⚡️

0 · Reply

Paxhawig May. 13 at 11:37 AM

$IXHL I will be in Dubai and killing Joel….

2 · Reply

Paxhawig May. 13 at 11:34 AM

$IXHL bullshit

1 · Reply

Willitgoup1982 May. 13 at 11:29 AM

$IXHL good morning how’s the Santa cult doing.

1 · Reply

Michaelthoaicaonguyen May. 13 at 11:26 AM

$IXHL the just filed 8K yesterday it’s in my post if you want to read more it. But there is nothing to earn. As long as there is no dilution, new ATM, new offering we are good. 8K, shows none of this. 10Q will be on 5/14 or sometime this remaining week. Not much to talk about 10Q. Beside not burning the cash we raised. We don’t have shit to earn.

0 · Reply

RogueFF7 May. 13 at 11:12 AM

$IXHL comments on social media were turned on for the MedTech award and just before Earnibgs release later this week. Definitely a sign of confidence by management imo but you do you.

2 · Reply

macdub8 May. 13 at 11:02 AM

$IXHL why do people get hyped about pre-market. This stock has done this for months pre-market but you NPCs start creaming your little tighty whities on a little bump up. For the 10000th time..low volume = big swings.

0 · Reply

Dalder May. 13 at 10:51 AM

$IXHL nice candle! About 3 in a row and we’re off to the races🤩

0 · Reply

LN1990 May. 13 at 10:34 AM

$IXHL right now, need 452.5% to break even, 2,275% rise in the SP itself to get to $100 a share.

1 · Reply

macdub8 May. 13 at 10:28 AM

$IXHL oh its up 1% pre-market. Get a grip

1 · Reply

Rasputi May. 13 at 10:26 AM

$IXHL ⬇️ This is our pledge. Nothing to say more. Print it and put it on your fridge door. 👊

0 · Reply

Gigi96 May. 13 at 10:23 AM

$IXHL boooom?

0 · Reply

stockro1 May. 13 at 10:23 AM

$IXHL 🌋

0 · Reply

Market Cap	54.05M
Revenue (ttm)	90,000.00
Net Income (ttm)	-46.89M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-52,100.00%
Debt to Equity Ratio	0.00

Volume	409,900
Avg Vol	580,184
Day's Range	N/A - N/A
Shares Out	11.93M
Stochastic %K	6%
Beta	7.22
Analysts	Hold
Price Target	N/A